Korean J Nephrol.  2003 Mar;22(2):219-227.

Clinical Characteristics of Peritoneal Fluid Eosinophilia in Patients on CAPD

Affiliations
  • 1Department of Internal Medicine, Konkuk University College of Medicine, Chungju, Korea. josong@kku.ac.kr
  • 2NIHC Ilsan Hospital, Ilsan, Korea.

Abstract

BACKGROUND
The clinical characteristics and significance of peritoneal fluid eosinophilia (PFE) in patients on continuous ambulatory peritoneal dialysis (CAPD) in Korea were uncertain. The present study was performed to clarify the clinical characteristics of PFE in our CAPD patients. METHODS: Between January 2000 and December 2001, we analyzed retrospectively the clinical data of 112 patients on CAPD at two renal centers.
RESULTS
The mean period of the observation was 12.6+/-6.7 months, and the total number of peritoneal effluent sampling was 1, 024 (10.5/patient-year). PFE was found in 4.4% of patients. The incidence of PFE was 4.25 per 100 patients/year. Sixty percent of patients with PFE experienced within 2 weeks of initiation of dialysis. The duration of PFE episode varied from 1 to 4 days with the mean value of 2.8 days. All PFE episodes except one patient with abdominal pain treated by oral prednisolone had no symptoms and was spontaneously resolved. The only distinction between the patients with PFE and those without was concomitant peripheral blood eosinophilia (80.0% vs. 15.8%, p=0.0027). Other factors such as age, sex, primary renal disease, bacterial peritonitis, previous use of heparin or antibiotics, blood in peritoneal fluid, and allergic history were not significantly different between the two groups.
CONCLUSION
The majority of PFE episode in CAPD patients developed within 2 weeks of initiation of dialysis and spontaneously resolved without treatment. Peripheral blood eosinophilia was a good predictor of PFE.

Keyword

Eosinophilia; Peritoneal fluid; Peritoneal dialysis; Continuous ambulatory; Eosinophilia; Peripheral blood

MeSH Terms

Abdominal Pain
Anti-Bacterial Agents
Ascitic Fluid*
Dialysis
Eosinophilia*
Heparin
Humans
Incidence
Korea
Peritoneal Dialysis
Peritoneal Dialysis, Continuous Ambulatory*
Peritonitis
Prednisolone
Retrospective Studies
Anti-Bacterial Agents
Heparin
Prednisolone
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr